Dechra Announces FDA Approval of Zygolide® (pergolide tablets) for the Control of Clinical Signs Associated with Pituitary Pars Intermedia Dysfunction (Equine Cushing’s Disease) in Horses Zygolide® is ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback